Last reviewed · How we verify
NCT05513859
Investigational Imaging Technique During Brain Surgery
NA trial testing Craniotomy in Astrocytoma in 24 participants. Suspended.
28 June 2026
Quick facts
| Lead sponsor | Emory University |
|---|---|
| Phase | NA |
| Status | Suspended |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 24 |
| Start date | 11 March 2024 |
| Primary completion | 28 June 2026 |
| Estimated completion | 23 June 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Craniotomy
- Quantitative Oblique Back-Illumination Microscopy
Conditions studied
- Astrocytoma — all drugs for Astrocytoma →
- Glioblastoma — all drugs for Glioblastoma →
- Oligodendroglioma — all drugs for Oligodendroglioma →
Sponsor
Emory University
Who can join
18 and older, any sex, with Astrocytoma or Glioblastoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This early phase I trial tests the safety and reliability of an investigational imaging technique called quantitative oblique back illumination microscopy (qOBM) during brain surgery for detecting brain tumors and brain tumor margins in patients with glioblastoma, astrocytoma, or oligodendroglioma. Surgical margins refer to the edge or border of the tissue removed in cancer surgery. qOBM may be able to assess and reveal brain tumor surgical margins in a more safe and reliable manner.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05513859
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Craniotomy
Trials testing the same drug.
- NCT05789394 — Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in · Phase 1 · recruiting
- NCT04261673 — Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma · NA · active not recruiting
- NCT02811614 — Minimally-invasive Surgery Versus Craniotomy in Patients With Supratentorial Hypertensive Intracerebral Hemorrhage · NA · completed
- NCT01413438 — Bevacizumab With or Without Surgery for Adult Glioblastomas · Phase 2 · withdrawn
Other recruiting trials for Astrocytoma
Currently open trials in the same condition.
- NCT06989086 — FearLess in NeuroOncology · NA · recruiting
- NCT06614855 — A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant G · Phase 1 · active not recruiting
- NCT06797661 — Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions. · NA · recruiting
- NCT06344130 — Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma · Phase 1 · recruiting
- NCT05879367 — Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma · Phase 1 · recruiting
Other Emory University trials
Trials by the same sponsor.
- NCT06143345 — HIIT in Isolated IFG: A Proof-of-Concept Study · NA · withdrawn
- NCT07189819 — Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait · NA · not yet recruiting
- NCT06451055 — Low-calorie Diet in Isolated Impaired Fasting Glucose · NA · not yet recruiting
- NCT07405476 — Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I · Phase 2 · recruiting
- NCT06708351 — Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05513859 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Emory University
- Last refreshed: 3 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05513859.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing